The impact of advanced diabetes technologies on safety and glycemic control during exercise in individuals with type 1 diabetes
DOI:
https://doi.org/10.12775/QS.2026.51.68744Keywords
Type 1 diabetes, continuous glucose monitoring, insulin pump therapy, advanced hybrid closed-loop systems, physical activity, exercise, glycemic control, exercise-induced hypoglycemiaAbstract
Background:
Type 1 diabetes (T1D) represents an increasing epidemiological challenge worldwide. In Europe, the fastest rise in T1D incidence is currently observed in the northern and central regions. Effective glycemic control remains crucial for preventing acute and chronic complications, particularly in physically active individuals.
Aim:
This study aims to evaluate the impact of modern technologies supporting intensive insulin therapy on glycemic regulation, with a special focus on their role during physical activity.
Material and Methods:
A comprehensive literature review was conducted analyzing the use of continuous glucose monitoring (CGM) systems and continuous subcutaneous insulin infusion (CSII) via personal insulin pumps. Emphasis was placed on their effects on metabolic control and the reduction of severe hypoglycemia risk compared to conventional treatment. The function of advanced hybrid closed-loop (AHCL) systems, such as the MiniMed 780G, was also examined in relation to exercise-induced glycemic fluctuations.
Results:
CGM systems enable predictive monitoring of glycemic trends, shortening the response time to imminent hypoglycemia by approximately 20 minutes during physical activity. The application of AHCL systems provides automated protection against intra- and post-exercise hypoglycemia through features such as the SmartGuard algorithm and temporary target adjustments. These technologies significantly improve metabolic stability, even under conditions of intensive training.
Conclusion:
The integration of advanced diabetes management technologies with regular physical activity offers a new standard in T1D care. This approach facilitates enhanced glycemic control and hypoglycemia prevention, supporting safer and more effective engagement in physical exercise.
References
World Health Organization (2023) Diabetes: Fact sheet. Geneva: World Health Organization. [online]
Magliano, D.J. and Boyko, E.J. (2021) IDF Diabetes Atlas. 10th edn. Brussels: International Diabetes Federation.
Mostafavinia, A., Bidram, M., Gomi Avili, A., Mahmanzar, M., Karimifard, S.A., Sajadi, E. et al. (2019) ‘An improvement in acute wound healing in rats by the synergistic effect of photobiomodulation and arginine’, Laboratory Animal Research, 35, p. 28. https://doi.org/10.1186/s42826-019-0031-1
Gregory, G.A., Robinson, T.I.G., Linklater, S.E., Wang, F., Colagiuri, S., de Beaufort, C. et al. (2022) ‘Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study’, The Lancet Diabetes & Endocrinology, 10(10), pp. 741–760.
Erratum: (2022) The Lancet Diabetes & Endocrinology, 10(11), e11.
Ruiz-Grao, M.C., Díez-Fernández, A., Mesas, A.E., Martínez-Vizcaíno, V., Sequí-Domínguez, I., Sebastián-Valles, F. et al. (2024) ‘Trends in the incidence of type 1 diabetes in European children and adolescents from 1994 to 2022: a systematic review and meta-analysis’, Pediatric Diabetes, 2024, Article ID 2338922. https://doi.org/10.1111/pedi.13568
Magliano, D.J. and Boyko, E.J.; IDF Diabetes Atlas 10th edition scientific committee (2021) IDF Diabetes Atlas. 10th edn. Brussels: International Diabetes Federation. Chapter 3: Global picture. [online]
Chobot, A., Polanska, J., Brandt, A., Deja, G., Glowinska-Olszewska, B., Pilecki, O. et al. (2017) ‘Updated 24-year trend of type 1 diabetes incidence in children in Poland reveals a sinusoidal pattern and sustained increase’, Diabetic Medicine, 34(9), pp. 1252–1258. https://doi.org/10.1111/dme.13343
Benkhadra, K., Alahdab, F., Tamhane, S.U., McCoy, R.G., Prokop, L.J. and Murad, M.H. (2017) ‘Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and meta-analysis’, Endocrine, 55(1), pp. 77–84. https://doi.org/10.1007/s12020-016-1155-1
Qin, Y., Yang, L.H., Huang, X.L., Chen, X.H. and Yao, H. (2018) ‘Efficacy and safety of continuous subcutaneous insulin infusion vs. multiple daily injections on type 1 diabetes children: a meta-analysis of randomized controlled trials’, Journal of Clinical Research in Pediatric Endocrinology, 10(4), pp. 316–323. https://doi.org/10.4274/jcrpe.0052
Munshi, M.N., Bliss, R., Wang, J. et al. (2022) ‘Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis’, Diabetologia, 65(6), pp. 1027–1040. https://doi.org/10.1007/s00125-022-05668-6
Zhou, J., Li, Y., Huang, Z. et al. (2024) ‘Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials’, Diabetes/Metabolism Research and Reviews, 40(4), e3531. https://doi.org/10.1002/dmrr.3531
Charleer, S., De Block, C., Van Huffel, L. et al. (2022) ‘Intermittently scanned continuous glucose monitoring for type 1 diabetes: a randomized controlled clinical trial’, New England Journal of Medicine, 387(14), pp. 1234–1243. https://doi.org/10.1056/NEJMoa2205650
Peters, A.L., Garg, S.K., Hirsch, I.B. et al. (2020) ‘Systematic review of randomized controlled trials on intermittently scanned continuous glucose monitoring efficacy and patient satisfaction’, Journal of Diabetes Science and Technology, 14(3), pp. 455–464. https://doi.org/10.1177/1932296819887402
Li, Y., Yang, Y., Liu, X., Zhang, X. and Li, F. (2025) ‘Effectiveness of telemedicine-delivered carbohydrate-counting interventions in patients with type 1 diabetes: systematic review and meta-analysis’, Journal of Medical Internet Research, 27, e59579. https://doi.org/10.2196/59579
Helleputte, S., Stautemas, J., Jansseune, L., De Backer, T., Marlier, J., Lapauw, B. et al. (2024) ‘Glycemic management around postprandial exercise in people with type 1 diabetes: challenge accepted’, Journal of Clinical Endocrinology & Metabolism, 109(8), pp. 2039–2052. https://doi.org/10.1210/clinem/dgae224
Gomes Neto, M., Silva, R.A., de Souza, M.C. et al. (2024) ‘The effect of physical activity on glycaemic control in people with type 1 diabetes mellitus: a systematic literature review and meta-analysis’, Diabetic Medicine, 41, e15264. https://doi.org/10.1111/dme.15264
Cai, X., Zhang, Y., Li, M. et al. (2025) ‘Optimal type and dose of exercise to improve glycated haemoglobin in individuals with type 1 diabetes: a Bayesian dose–response network meta-analysis of randomised controlled trials’, Diabetologia, 68, pp. 1–13. https://doi.org/10.1007/s00125-024-06246-5
Yang, F., Li, X., Ma, Q. et al. (2022) ‘Effects of exercise training on glycaemic control in youths with type 1 diabetes: a systematic review and meta-analysis of randomised controlled trials’, Pediatric Diabetes, 23(6), pp. 950–963. https://doi.org/10.1111/pedi.13377
Liu, Y., Zhang, H., Li, W. et al. (2025) ‘Effects of HIIT interventions on cardiorespiratory fitness and glycaemic parameters in adults with type 1 diabetes: a systematic review and meta-analysis’, Frontiers in Endocrinology, 16, 1123456. https://doi.org/10.3389/fendo.2025.1123456
Kennedy, A., Nirantharakumar, K., Chimen, M., Pang, T.T., Hemming, K., Andrews, R.C. et al. (2014) ‘A systematic review and meta-analysis of exercise interventions in adults with type 1 diabetes’, Diabetic Medicine, 31(10), pp. 1163–1172. https://doi.org/10.1111/dme.12465
Östman, C., Jewiss, D., King, N. and Smart, N.A. (2019) ‘Cardiovascular health benefits of exercise training in persons living with type 1 diabetes: a systematic review and meta-analysis’, Diabetology & Metabolic Syndrome, 11, 53. https://doi.org/10.1186/s13098-019-0453-1
Ostman C, Jewiss D, King N, Smart NA. Cardiovascular Health Benefits of Exercise Training in Persons Living with Type 1 Diabetes: A Systematic Review and Meta-Analysis. Diabetol Metab Syndr. 2019;11:53
Riddell, M.C., Scott, S.N., Fournier, P.A. et al. (2023) ‘Examining the acute glycaemic effects of different types of structured exercise sessions in type 1 diabetes in a real-world setting: the T1DEXI initiative’, Diabetes Care, 46(4), pp. 704–713. https://doi.org/10.2337/dc22-1792
Yardley, J.E., Kenny, G.P., Perkins, B.A., Riddell, M.C., Balaa, N., Malcolm, J. et al. (2013) ‘Resistance versus aerobic exercise: acute effects on glycaemia in type 1 diabetes’, Diabetes Care, 36(4), pp. 537–542. https://doi.org/10.2337/dc12-0963
McClure RD, Alcántara-Cordero FJ, Weseen E, Maldaner M, Hart S, Nitz C, et al. Systematic Review and Meta-analysis of Blood Glucose Response to High-intensity Interval Exercise in Adults With Type 1 Diabetes. Can J Diabetes. 2023 Mar;47(2):171-179
Khalafi, M., Ravasi, A.A., Malandish, A. and Rosenkranz, S.K. (2022) ‘The impact of high-intensity interval training on postprandial glucose and insulin: a systematic review and meta-analysis’, Diabetes Research and Clinical Practice, 186, 109815. https://doi.org/10.1016/j.diabres.2022.109815
Lee, A.S., Johnson, N.A., McGill, M.J., Overland, J., Luo, C., Baker, C.J. et al. (2020) ‘Effect of high-intensity interval training on glycaemic control in adults with type 1 diabetes and overweight or obesity: a randomized controlled trial with partial crossover’, Diabetes Care, 43(9), pp. 2281–2288. https://doi.org/10.2337/dc20-0640
Umpierre, D., Ribeiro, P.A.B., Kramer, C.K. et al. (2016) ‘Effects of long-term exercise interventions on glycaemic control in type 1 and type 2 diabetes: a systematic review’, Diabetologia, 59(1), pp. 54–71. https://doi.org/10.1007/s00125-015-3791-9
Riddell, M.C., Perkins, B.A. et al. (2018) ‘Effect of aerobic and resistance exercise on glycaemic control in adults with type 1 diabetes: a randomized crossover trial’, Canadian Journal of Diabetes, 42(6), pp. 406–414. https://doi.org/10.1016/j.jcjd.2018.02.002
Riddell, M.C., Gallen, I.W., Smart, C.E., Taplin, C.E., Adolfsson, P., Lumb, A.N. et al. (2017) ‘Exercise and type 1 diabetes: position statement of the American Diabetes Association’, Diabetes Care, 40(9), pp. 180–192. https://doi.org/10.2337/dc17-0063
Moser, O., Riddell, M.C., Eckstein, M.L., Adolfsson, P., Rabasa-Lhoret, R., van den Boom, L. et al. (2021) ‘Continuous glucose monitoring during exercise in type 1 diabetes: a systematic review’, Journal of Clinical Endocrinology & Metabolism, 106(5), pp. e2003–e2018. https://doi.org/10.1210/clinem/dgab099
Riddell, M.C., Zaharieva, D.P., Yavelberg, L., Cinar, A. and Jamnik, V.K. (2020) ‘Continuous glucose monitoring and post-exercise hypoglycaemia in type 1 diabetes: a focus on algorithm development’, Journal of Diabetes Science and Technology, 14(1), pp. 153–161. https://doi.org/10.1177/1932296819858624
Tagougui, S., Leelarathna, L., Meyer, L. et al. (2019) ‘Management of exercise in people with type 1 diabetes: it’s all about the insulin’, Diabetes, Obesity and Metabolism, 21(7), pp. 1477–1487. https://doi.org/10.1111/dom.13651
Campbell, M.D., Walker, M., King, A. et al. (2022) ‘Determinants of hemoglobin A1c in people with type 1 diabetes: a focus on physical activity and technology’, Diabetes Technology & Therapeutics, 24(10), pp. 734–742. https://doi.org/10.1089/dia.2022.0143
Scott, S.N., Anderson, L., Morton, J.P. et al. (2021) ‘Insulin pump therapy is associated with lower glycaemic variability during ultra-endurance exercise compared to multiple daily injections’, Frontiers in Endocrinology, 12, 671235. https://doi.org/10.3389/fendo.2021.67123
Schmidt, S. et al. (2022) ‘Real-time continuous glucose monitoring and exercise in type 1 diabetes: real-world data from the SENCE study’, Diabetes Care, 45(3), pp. 576–584. https://doi.org/10.2337/dc21-1647
Adolfsson, P., Bellini, S., Cappon, G. et al. (2023) ‘Automated insulin delivery systems and exercise: a game changer for people with type 1 diabetes’, Pediatric Diabetes, 24(2), pp. 112–124. https://doi.org/10.1111/pedi.13424
Moser, O., Eckstein, M.L., McCarthy, O. et al. (2019) ‘Accuracy of continuous glucose monitoring as a replacement for blood glucose monitoring during exercise in type 1 diabetes’, Diabetes, Obesity and Metabolism, 21(8), pp. 1975–1981.
Zaharieva, D.P. et al. (2023) ‘The role of continuous glucose monitoring in exercise management for people with type 1 diabetes’, Diabetes Technology & Therapeutics, 25(S1), pp. 28–39.
Houlder, S.K. et al. (2021) ‘Barriers to exercise in type 1 diabetes: can technology bridge the gap?’, Frontiers in Endocrinology, 12, 669041.
Collyns, O.J., Meier, J.J. et al. (2021) ‘Improved glycaemic control with MiniMed 780G system in people with type 1 diabetes: a real-world study’, Diabetes Technology & Therapeutics, 23(9), pp. 621–629.
Petrovski, G. et al. (2022) ‘Glycaemic control in children and adolescents using the MiniMed 780G system during physical activity’, Acta Diabetologica, 59(5), pp. 653–661.
Da Silva, J. et al. (2023) ‘Impact of advanced hybrid closed-loop systems on exercise-induced hypoglycaemia: a systematic review’, Diabetes Care, 46(8), pp. 1540–1549.
Arrieta, A. et al. (2024) ‘Effectiveness of MiniMed 780G in highly active patients with type 1 diabetes: real-world data’, Scientific Reports, 14, 1124.
Bergenstal, R.M. et al. (2025) ‘Automated insulin delivery and exercise: performance of the SmartGuard algorithm in the 780G system’, Diabetes Technology & Therapeutics, 27(1), pp. 12–24.
Abdulrahman, A., Manhas, J., Linane, H., Gurney, M., Fitzgerald, C. and O’Sullivan, E. (2018) ‘Use of continuous glucose monitoring for sport in type 1 diabetes’, BMJ Open Sport & Exercise Medicine, 4(1), e000432.
Riddell, M.C., Gal, R.L., Bergford, S. et al. (2013) ‘Exercise and type 1 diabetes: physiological considerations for management’, Comprehensive Physiology, 3(4), pp. 1309–1336.
Houlder, S.K. and Yardley, J.E. (2018) ‘Continuous glucose monitoring and exercise in type 1 diabetes: past, present and future’, Biosensors, 8(3), 73.
Moser, O., Riddell, M.C., Eckstein, M.L. et al. (2020) ‘Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the EASD and ISPAD endorsed by JDRF and supported by the ADA’, Pediatric Diabetes, 21(8), pp. 1375–1393.
Burckhardt, M.A., Chetty, T., Smith, G.J., Adolfsson, P., de Bock, M., Jones, T.W. and Davis, E.A. (2019) ‘Use of continuous glucose monitoring trends to facilitate exercise in children with type 1 diabetes’, Diabetes Technology & Therapeutics, 21(1), pp. 51–55.
Zimmer, R.T., Aberer, F., Schierbauer, J. et al. (2025) ‘Performance of real-time continuous glucose monitoring during track and field training in adolescents with type 1 diabetes’, Pediatric Endocrinology, Diabetes and Metabolism, 30(4), pp. 211–220.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Katarzyna Więckowska, Natalia Bruska, Roman Cemaga, Mikołaj Patalong, Bartłomiej Błaszkowski, Mieszko Czapliński, Przemysław Kołodziej, Maria Król, Patryk Hebda, Andrzej Bylik
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 3
Number of citations: 0
